ADMS - Adamas Pharmaceuticals Inc. (ADMS) CEO Neil McFarlane on Q3 2019 Results - Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (ADMS)
Q3 2019 Earnings Conference Call
November 07, 2019, 16:30 ET
Company Participants
Peter Vozzo - Westwicke Partners
Neil McFarlane - CEO & Director
Vijay Shreedhar - Chief Commercial Officer
Rajiv Patni - Chief Medical Officer
Christopher Prentiss - CFO & Principal Financial Officer
Conference Call Participants
Roanna Ruiz - SVB Leerink
Joshua Schimmer - Evercore ISI
David Amsellem - Piper Jaffray Companies
Kenneth Cacciatore - Cowen and Company
Timothy Lugo - William Blair & Company
Raghuram Selvaraju - H.C. Wainwright & Co.
Presentation
Operator
Ladies and gentlemen, thank you for standing